Cancer
Unexpected feature 'lock' cancer of 3 types of arthritis drugs
A popular anti-arthritis medication may be prescribed for future breast cancer treatment, because it may reduce the risk of metastatic bone disease to only one third.
Browse ScienceInfo articles and explainers related to Canakinumab.
2 published items.
A popular anti-arthritis medication may be prescribed for future breast cancer treatment, because it may reduce the risk of metastatic bone disease to only one third.
The new drug is able to reduce the risk of heart attack by a quarter, halving the risk of dying from cancer and protecting the body against gout and arthritis.